Carregant...
Psychiatric adverse events with hydroxychloroquine during COVID-19 pandemic
• HCQ, well known in rheumatology, dermatology and tropical medicine is now considered in the treatment and prophylaxy for the SARS-CoVid19. • Mental and neurological manifestations should be assessed following the use of hydrochloroquine particularly following prophylactic use. • For acute malaria...
Guardat en:
| Publicat a: | Asian J Psychiatr |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier B.V.
2020
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7305495/ https://ncbi.nlm.nih.gov/pubmed/32603983 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajp.2020.102203 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|